Sale!

GNAO1 Gene Early infantile epileptic encephalopathy type 17 Genetic Test Cost

Name: GNAO1 Gene Early infantile epileptic encephalopathy type 17 Genetic Test Cost
SKU: TEST-1284
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GNAO1 gene is crucial for proper brain function and development. Mutations in this gene can lead to a rare but severe condition known as Early Infantile Epileptic Encephalopathy Type 17 (EIEE17). This condition is characterized by frequent seizures that begin in the first few months of life, developmental delays, and other neurological issues. Genetic testing for mutations in the GNAO1 gene is essential for diagnosing EIEE17, guiding treatment options, and offering genetic counseling for families.

DNA Labs UAE offers a comprehensive genetic test to detect mutations in the GNAO1 gene, aiding in the diagnosis of Early Infantile Epileptic Encephalopathy Type 17. The test is a crucial step for families seeking answers about this challenging condition. The cost of the test is 4400 AED, reflecting the specialized analysis required to accurately identify the presence of mutations in the GNAO1 gene. By opting for this test, families can gain valuable insights into their child’s condition, enabling better management and care strategies tailored to their specific needs.

Description

GNAO1 Gene Early Infantile Epileptic Encephalopathy Type 17 Genetic Test

Test Name: GNAO1 Gene Early Infantile Epileptic Encephalopathy Type 17 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GNAO1 Gene Early Infantile Epileptic Encephalopathy Type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GNAO1 Gene Early Infantile Epileptic Encephalopathy Type 17.

Test Details: The GNAO1 gene is associated with a rare genetic disorder called Early Infantile Epileptic Encephalopathy Type 17 (EIEE17). This disorder is characterized by seizures that begin in infancy and developmental delay. The GNAO1 gene provides instructions for making a protein that is involved in transmitting signals within neurons in the brain. Mutations in this gene can disrupt the normal function of the protein, leading to the development of EIEE17.

NGS (Next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once. This test can identify mutations in the GNAO1 gene that are associated with EIEE17. NGS testing is a powerful tool for diagnosing rare genetic disorders like EIEE17, as it can detect mutations that might be missed by other types of genetic testing.

Early diagnosis of EIEE17 is important for providing appropriate treatment and support to affected individuals and their families.

Test Name	GNAO1 Gene Early infantile epileptic encephalopathy type 17 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for GNAO1 Gene Early infantile epileptic encephalopathy type 17 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GNAO1 Gene Early infantile epileptic encephalopathy type 17
Test Details	The GNAO1 gene is associated with a rare genetic disorder called Early infantile epileptic encephalopathy type 17 (EIEE17). This disorder is characterized by seizures that begin in infancy and developmental delay. The GNAO1 gene provides instructions for making a protein that is involved in transmitting signals within neurons in the brain. Mutations in this gene can disrupt the normal function of the protein, leading to the development of EIEE17. NGS (Next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once. This test can identify mutations in the GNAO1 gene that are associated with EIEE17. NGS testing is a powerful tool for diagnosing rare genetic disorders like EIEE17, as it can detect mutations that might be missed by other types of genetic testing. Early diagnosis of EIEE17 is important for providing appropriate treatment and support to affected individuals and their families.